STAT+: Sarepta names Michael Severino, former Tessera CEO, as new chief executive
The beleaguered Sarepta Therapeutics named Michael Severino, who previously led Tessera Therapeutics, as its new CEO.
Category
Healthcare
Healthcare and public health reporting covering medical research, pharmaceuticals, hospital systems, and federal health policy. MAP Verified journalism.
STAT+: Pharma’s drug spending deflection
Job lock, surging prescription drug costs, No Surprises Act update, and more from STAT's Health Care Inc.
These insect submariners survive depths that should crush them
Lake fly larvae plunge more than 200 meters into Lake Malawi each day to hide from…
An FDA panel recommended that compounding pharmacies be allowed to make two more peptides, a step…
Your dreams aren’t random. Your brain is rewriting reality
Dreams are not random mental noise. A large study of more than 3,700 dream and waking…
STAT+: Ahead of hearing, FDA questions the efficacy of Capricor’s Duchenne drug
Ahead of a hearing, the FDA raised questions about the benefits of a Duchenne treatment from…
Scientists reveal what sparkling water really does to your teeth
Unsweetened sparkling water may offer a tooth-friendlier alternative to sugary soda, according to a small preliminary…
500,000-year-old elephant bone hammer shows ancient humans were master toolmakers
Early humans in England crafted a rare piece of elephant bone into a reusable hammer for…
A trend that isn’t fading, ultra-processed baby foods
An FDA advisory panel serves some peptide wins, a measles record, and more health news from…
Why Jupiter has several giant moons but Saturn has only Titan
Young Jupiter’s powerful magnetic field may have created a safe zone where several large moons could…